Cancer T cell therapy expands

Nature Medicine

Volumn 9, Issue 3, 2003, Pages 257-258

  Becknell, Brian ^a   Caligiuri, Michael A ^b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GANCICLOVIR; INTERLEUKIN 15; T LYMPHOCYTE RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN BINDING; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; BURKITT LYMPHOMA; CANCER IMMUNOTHERAPY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DRUG TARGETING; GENETIC ENGINEERING; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SUICIDE GENE; T LYMPHOCYTE;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD19; B-LYMPHOCYTES; CELLS, CULTURED; COCULTURE TECHNIQUES; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-15; INTERLEUKIN-2; MICE; MICE, SCID; NEOPLASMS; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0037349924     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0303-257     Document Type: Short Survey

References (5)

1. Brentjens, R. et al. Eradication of systemic B cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15. Nat. Med. 9, 279-286 (2003).
2. Frauwirth, K.A. & Thompson, C.B. Activation and inhibition of lymphocytes by costimulation. J. Clin. Invest. 109, 295-299 (2002).
3. + T cells in vivo by IL-15. Immunity 8, 591-599 (1998).
4. Maher, J., Brentjens, R.J., Gunset, G., Riviere, I. & Sadelain, M. Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ/CD28 receptor. Nat. Biotechnol. 20, 70-75 (2002).
5. Kaiser, I. Seeking the cause of induced leukemias in X-SCID trial. Science 299, 495 (2003).